SEOUL, Südkorea, 18. Februar 2025 /PRNewswire/ — Am 17. Februar gab VIVOZON Pharmaceutical bekannt, dass sein nicht-opioides Analgetikum UNAFRA Inj. am 12. Dezember 2024 zugelassen wurde. (Aktiver Wirkstoff: Opiranserin HCl) hat vom Ministerium für Lebensmittel- und…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.